Correspondence 0001437749-24-018972 from Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Date: June 3, 2024 · CIK: 0000922247 · Accession: 0001437749-24-018972
AI Filing Summary & Sentiment
File numbers found in text: 333-279703
Show Raw Text
CORRESP 1 filename1.htm ctdh20240531_corresp.htm 6714 NW 16th Street, Suite B Gainesville, FL 32653 June 3, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Doris Stacey Gama Re: Cyclo Therapeutics, Inc. Registration Statement on Form S-3 Filed May 24, 2024 File No. 333-279703 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclo Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time, on June 4, 2024, or as soon thereafter as is practicable. The Company requests that it be notified of such effectiveness by a telephone call to Sarah Hewitt of Fox Rothschild LLP at (212) 878-1435. Thank you for your assistance in this matter. Should you have any questions, please call Ms. Hewitt. Very truly yours, /s/ N. Scott Fine N. Scott Fine Chief Executive Officer cc: Sarah Hewitt, Esq.